Try the modernized beta website. Learn more about the modernization effort.
Working… Menu
Trial record 2 of 8 for:    Dapansutrile

Safety and Efficacy of Dapansutrile for Treatment of Moderate COVID-19 Symptoms and Evidence of Early Cytokine Release Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04540120
Recruitment Status : Recruiting
First Posted : September 7, 2020
Last Update Posted : January 26, 2022
CTI Clinical Trial and Consulting Services
Information provided by (Responsible Party):
Olatec Therapeutics LLC

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : June 2022
Estimated Study Completion Date : July 2022